Interleukin Genetics, Inc. announced today that it has entered into a Securities Purchase Agreement with various accredited investors to raise gross proceeds of $5.0 million in a private placement financing. The syndicate is comprised of new and existing investors including two leading life sciences investment firms, New Enterprise Associates and Bay City Capital.
http://ift.tt/1E9RhSn
http://ift.tt/1E9RhSn
No comments:
Post a Comment